DNIB Unwind Inc

bind therapeutics is a biotechnology company incorporated in 2006; pfizer acquired substantially all of its assets in 2016. bind’s product candidates were based on proprietary polymeric nanoparticles called accurins®, which are engineered to target specific cells and tissues in the body at sites of disease. accurins®, which continue to be developed with pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.

Experimente rapidamente com tomba.io.

Fatos sobre DNIB Unwind Inc

Local na rede Internet

bindtherapeutics.com

Fundado

2006

Número de empregados

1-10

Indústria

biotechnology

País

US

Estado

Massachusetts

Cidade

Cambridge

Endereço da Rua

-71.10

Número de telefone

(617) 491-3400

Email pattern

{f}{last}

Email Accept all Status

False

Email Blocked Status

False

Whois Data de criação

February 27th 2013, 05:54:42 pm

RWhois

www.markmonitor.co...

Whois Name

MarkMonitor Inc.

Total Emails

36

Total Personal Emails

32

Total Generic Emails

4

Last updated

April 4th 2023, 09:05:41 pm

Encontre o e-mail de qualquer pessoa por trás de qualquer site

Contas sociais de DNIB Unwind Inc

Todos os endereços de e-mail para bindtherapeutics.com

nicholas boylan

n***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

scientist

0 Sources

tatiana sitnova

t***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

Legal Director

0 Sources

dan koerwer

d***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

chief business officer

0 Sources

scott minick

s***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

ceo

0 Sources

christina seretta

c***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

hr associate

0 Sources

brenda duane

b***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

director hr

0 Sources

laurie travers

l***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

staffing consultant

0 Sources

scott minick

s***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

0 Sources

jean kung

j***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

clinical project manager data manager

0 Sources

peter endicott

p***@bindtherapeutics.com
Não foi possível encontrar este endereço de e-mail disponível publicamente na Web.

head facilities

0 Sources

26 mais para sua pesquisa bindtherapeutics.com

Crie uma conta para descobrir endereços de e-mail, obter resultados completos, filtros de pesquisa, downloads de CSV e muito mais.

Formato de Email

EmailPattern #

johndoe@bindtherapeutics.com

{first}{last}

No

john.doe@bindtherapeutics.com

{first}.{last}

No

john-doe@bindtherapeutics.com

{first}-{last}

No

doejohn@bindtherapeutics.com

{last}{first}

No

doe.john@bindtherapeutics.com

{last}.{first}

No

doe-john@bindtherapeutics.com

{last}-{first}

No

jdoe@bindtherapeutics.com

{f}{last}

Available

j.doe@bindtherapeutics.com

{f}.{last}

No

j-doe@bindtherapeutics.com

{f}-{last}

No

johnd@bindtherapeutics.com

{first}{l}

No

john.d@bindtherapeutics.com

{first}.{l}

No

john-d@bindtherapeutics.com

{first}-{l}

No

djohn@bindtherapeutics.com

{l}{first}

No

d.john@bindtherapeutics.com

{l}.{first}

No

d-john@bindtherapeutics.com

{l}-{first}

No

doej@bindtherapeutics.com

{last}{f}

No

doe.j@bindtherapeutics.com

{last}.{f}

No

doe-j@bindtherapeutics.com

{last}-{f}

No

john@bindtherapeutics.com

{first}

No

doe@bindtherapeutics.com

{last}

No

jd@bindtherapeutics.com

{f}{l}

No

j.d@bindtherapeutics.com

{f}.{l}

No

j-d@bindtherapeutics.com

{f}-{l}

No

dj@bindtherapeutics.com

{l}{f}

No

d.j@bindtherapeutics.com

{l}.{f}

No

d-j@bindtherapeutics.com

{l}-{f}

No

Perguntas frequentes sobre DNIB Unwind Inc

Where is DNIB Unwind Inc's physical location?

DNIB Unwind Inc is headquartered in US.

Can you detail the whois information for DNIB Unwind Inc's domain?

DNIB Unwind Inc's domain whois information was last updated on 2013-02-27T18:54:42+01:00, The registrant name associated with the domain is MarkMonitor Inc..

What are the key industries and company size for DNIB Unwind Inc?

DNIB Unwind Inc operates within the biotechnology industry and reports a company size of 1-10 employees.

Can you provide DNIB Unwind Inc's contact information?

Certainly, DNIB Unwind Inc can be reached at the phone number (617) 491-3400.

What is the total number of emails cataloged by DNIB Unwind Inc?

As of the latest update, DNIB Unwind Inc has cataloged a total of 36 emails.

Does DNIB Unwind Inc have any restrictions on the types of emails it accepts?

DNIB Unwind Inc does not indiscriminately accept all types of emails. The platform has specific criteria and verification processes to ensure the validity and relevance of the email addresses it lists, reflecting its policy on accepting specific types of emails.

Is there any block on DNIB Unwind Inc's email finding capabilities?

No, there is no block on DNIB Unwind Inc's email finding capabilities, confirming that the service operates freely without no restrictions.

How can one connect with DNIB Unwind Inc on social media?

DNIB Unwind Inc maintains an active presence on major social media platforms, including Twitter (BINDTx), Facebook (BINDTHERA), and LinkedIn (3050288).

What email pattern does DNIB Unwind Inc utilize for creating email addresses?

DNIB Unwind Inc employs the email naming pattern '{f}{last}''

What is the geographical location of DNIB Unwind Inc's headquarters?

DNIB Unwind Inc is headquartered in Cambridge, Massachusetts, US. The precise location is marked by the street address -71.10.

Procurar empresas

Nosso índice de empresas contém centenas de milhares de empresas.